Companies · Other Health Care

3Oe Scientific, LLC

CARMEL · Other Health Care

Diligence memoA one-page analyst read on 3Oe Scientific, LLC — recommendation, valuation, rhythm, risks.
$3.7M
Total raised · real
2
Rounds
0.1×
Latest step-up
Top 42%
Sector rank · raised
Seed
Latest stage · inferred · Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

3Oe Scientific, LLC looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.65× the median modeled value of Seed Other Health Care companies in 2019–2021 (211 peers) — value vs value, same stage and era.
Dormant
  • Last raise 5.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

3Oe Scientific, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
7.4 yr record
Peak capital year was 2020 with $2.8M across 2 filings.
Market position
ahead of 59% of Other Health Care peers
Capital scale is ahead of 59% of Other Health Care peers; modeled value is above 69% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2020: $2.8M across 2 filings.
  • Largest single filing was $2.4M on 2020-07-21.
  • Filing rows sum to $4.0M, while canonical raised total is $3.7M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

3Oe Scientific, LLC is one of 5377 Other Health Care companies tracked from CARMEL. By capital raised it ranks mid-pack (ahead of 59% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
5
Investors (latest)
2018
Year incorporated
2020-07-21
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2019-02-01 Raised $1.3M (real) Modeled valuation $31M (est)$1.3M$31MSeed2019Seed · 2020-07-21 Raised $2.4M (real) Modeled valuation $59M (est)$2.4M$59MSeed2020Pre-Seed · 2020-07-21 Raised $326K (real) Modeled valuation $9.8M (est)$326K$9.8MPre-Seed2020+$2.4M+$326KCumulative $4.0M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.3M · 2019
Seed extension$2.4M · 2020
Bridge · Seed-stage$326K · 2020smaller follow-on

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$59.1M
Base estimate est.
$2.1M
Conservative case
$457.2M
Upside case
$12.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $31.5M · 2019-02-012019Seed · modeled $59.1M · 2020-07-21Pre-Seed · modeled $9.8M · 2020-07-212020
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
6.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
9 mo
Avg between rounds
$2.5M/yr
Capital velocity
7.4 yr
On record since
2019
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 1.5× above median
This company$3.7M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.2× of median
This company$326K
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 2.7× above median
This company$59.1M
Sector median$22.1M

Raised more than 59% of sector peers (real $). Modeled value above 69% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #42 of 211.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Crossroads at Delta Memory · Seed Raised $4.3M · modeled $99.1M (est)Noninvasix, Inc. · Seed Raised $4.0M · modeled $97.9M (est)CPIV Haven Holdings, LLC · Seed Raised $3.8M · modeled $92.9M (est)Cane Ip Key Holdings, Llc · Seed Raised $3.5M · modeled $87.4M (est)Hospi Corp · Seed Raised $7.0M · modeled $86.6M (est)Functional Fluidics Inc. · Seed Raised $3.6M · modeled $84.2M (est)Starling Solutions Inc. · Seed Raised $3.8M · modeled $82.2M (est)CairnSurgical, Inc. · Seed Raised $3.3M · modeled $81.5M (est)DxLab Inc. · Seed Raised $4.0M · modeled $81.5M (est)Freedom Center of Beacon, LLC · Seed Raised $3.2M · modeled $80.5M (est)GenomOncology, LLC · Seed Raised $5.8M · modeled $79.3M (est)Kingwood Surgicenter, LLC · Seed Raised $3.0M · modeled $74.7M (est)3Oe Scientific, LLC (this company) Raised $3.7M · modeled $59.1M (est)3Oe Scientific, LLC
CompanyStageRaised · realValue · estvs peer med.
Crossroads at Delta MemorySeed$4.3M$99.1M2.77×
Noninvasix, Inc.Seed$4.0M$97.9M2.73×
CPIV Haven Holdings, LLCSeed$3.8M$92.9M2.60×
Cane Ip Key Holdings, LlcSeed$3.5M$87.4M2.44×
Hospi CorpSeed$7.0M$86.6M2.42×
Functional Fluidics Inc.Seed$3.6M$84.2M2.35×
Starling Solutions Inc.Seed$3.8M$82.2M2.30×
CairnSurgical, Inc.Seed$3.3M$81.5M2.28×
DxLab Inc.Seed$4.0M$81.5M2.28×
Freedom Center of Beacon, LLCSeed$3.2M$80.5M2.25×
GenomOncology, LLCSeed$5.8M$79.3M2.22×
Kingwood Surgicenter, LLCSeed$3.0M$74.7M2.09×
3Oe Scientific, LLC this companySeed$3.7M$59.1M1.65×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.3M2019-02-01$6.3M$31.5M90%
Seed$2.4M2020-07-21$12.2M$59.1M90%
Pre-Seed$326K2020-07-21$1.8M$9.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.3M2019-02-01
    • First recorded raise — entered as Seed.
    • 24 investors on this round.
  2. Seed$2.4M2020-07-21
    • Raised 18 mo later, in step with the ~14 mo sector norm.
    • Round 1.9× larger than the prior — scaling up.
    • 38 investors on this round.
  3. Pre-Seed$326K2020-07-21
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 7.5× smaller than the prior — bridge or down round.
    • 5 investors on this round.
Intelligence
2021 ~Q2
Modeled next raise · ~9mo cadence
$326K
Modeled next size est.range $326K$522K
0.1×
Last step-up
$2.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Sam Howard1 other2019-02
Anthony W. LeCount2020-07
Bob Lubitz2019-02
Bob W. Lubitz2020-07
Doug Kahlenbeck2019-02
Sam W. Howard2020-07
Thomas Foust2019-02
Thomas W. Foust2020-07
Tony LeCount2019-02
Registry & provenance

3Oe Scientific, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1798519
SEC CIK
2018
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Medencentive LlcOther Health CareSeed$3.7M$52.0Msame sector · same stage
Cathera, Inc.Other Health CareSeed$3.8M$62.2Msame sector · same stage
1288079 B.C. Ltd.Other Health CareSeed$3.7M$65.9Msame sector · same stage
InVivoLink, Inc.Other Health CareSeed$3.6M$45.9Msame sector · same stage
Stepping Stone Dental Partners LLCOther Health CareSeed$3.6M$64.4Msame sector · same stage
RP Redwood Holdco, LLCOther Health CareSeed$3.9M$59.4Msame sector · same stage
OBMedical CoOther Health CareSeed$3.9M$65.6Msame sector · same stage
Akumin Inc.Other Health CareSeed$3.9M$67.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
3Analytics, Inc.Other Health CarePre-Seed$14.6M86%
Trio Medical CorpHealthtechSeed$9.7M86%
3PH Alliance, Inc.Other Health CareSeed$21.3M86%
Third Eye Health, Inc.HealthtechSeries A$40.8M85%
3RC Home Health Holdings, LLCHealthtechSeries A$261.9M85%
Bsc 3 LlcOther Health CareSeed$8.1M85%
MR3 Health, Inc.HealthtechSeed$12.5M84%
Trilogy Investors, LLCOther Health CareSeed$49.6M84%
Frequently asked
How much funding has 3Oe Scientific, LLC raised?
3Oe Scientific, LLC has raised approximately $3.7M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is 3Oe Scientific, LLC's estimated valuation?
Provath's modeled valuation for 3Oe Scientific, LLC is approximately $59.1M (modeled range $2.1M–$457.2M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is 3Oe Scientific, LLC at?
3Oe Scientific, LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Tue Jul 21.
What does 3Oe Scientific, LLC do and where is it based?
3Oe Scientific, LLC operates in the Other Health Care sector, based in CARMEL.
Explore related

See where 3Oe Scientific, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at 3Oe Scientific, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.